Literature DB >> 12060766

Molecular characterization of antibody specificities against myelin/oligodendrocyte glycoprotein in autoimmune demyelination.

Hans-Christian von Büdingen1, Stephen L Hauser, Antje Fuhrmann, Cameron B Nabavi, Joy I Lee, Claude P Genain.   

Abstract

Myelin/oligodendrocyte glycoprotein (MOG) is a target antigen for myelin-destructive Abs in autoimmune central nervous system demyelinating disorders. Little is known about the molecular and structural basis of these pathogenic Ab responses. Here, we have characterized anti-MOG Ab specificities in the marmoset model of experimental allergic encephalomyelitis, by means of a combinatorial IgG-Fab library. We found that a diverse population of Ig genes encodes for auto-Abs that exclusively recognize conformation-dependent antigenic targets on MOG. These antigenic domains correspond to exposed epitopes in vivo, as the Fab fragments recognize native MOG in situ in marmoset brain tissue. The Ab fragments described here represent Ab specificities that are common constituents of the humoral immune repertoire against MOG in outbred populations, as demonstrated by their ability to displace native anti-MOG Abs present in sera from MOG-immune marmosets and patients with multiple sclerosis. Furthermore, neuropathological analysis and characterization of Ab epitope specificities in animals immunized with MOG or MOG-derived peptides revealed that only conformation-dependent Abs are associated with demyelinating activity, suggesting that epitope recognition is an important factor for Ab pathogenicity. Our findings provide novel and unexpected knowledge on the diversity of anti-MOG Ab responses in nonhuman primates and humans, and will permit the dissection of pathogenic auto-Ab properties in multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12060766      PMCID: PMC123046          DOI: 10.1073/pnas.122092499

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

Review 1.  B cells and antibodies in CNS demyelinating disease.

Authors:  A H Cross; J L Trotter; J Lyons
Journal:  J Neuroimmunol       Date:  2001-01-01       Impact factor: 3.478

2.  Differential ultrastructural localization of myelin basic protein, myelin/oligodendroglial glycoprotein, and 2',3'-cyclic nucleotide 3'-phosphodiesterase in the CNS of adult rats.

Authors:  C Brunner; H Lassmann; T V Waehneldt; J M Matthieu; C Linington
Journal:  J Neurochem       Date:  1989-01       Impact factor: 5.372

Review 3.  Inflammation in the nervous system: the human perspective.

Authors:  J Bauer; H Rauschka; H Lassmann
Journal:  Glia       Date:  2001-11       Impact factor: 7.452

4.  B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions.

Authors:  S E Baranzini; M C Jeong; C Butunoi; R S Murray; C C Bernard; J R Oksenberg
Journal:  J Immunol       Date:  1999-11-01       Impact factor: 5.422

5.  Antibody response in Lewis rats injected with myelin oligodendrocyte glycoprotein derived peptides.

Authors:  M Ichikawa; T G Johns; M Adelmann; C C Bernard
Journal:  Int Immunol       Date:  1996-11       Impact factor: 4.823

6.  Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis.

Authors:  Y Qin; P Duquette; Y Zhang; P Talbot; R Poole; J Antel
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

7.  T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis.

Authors:  J Sun; H Link; T Olsson; B G Xiao; G Andersson; H P Ekre; C Linington; P Diener
Journal:  J Immunol       Date:  1991-03-01       Impact factor: 5.422

8.  The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat.

Authors:  M Adelmann; J Wood; I Benzel; P Fiori; H Lassmann; J M Matthieu; M V Gardinier; K Dornmair; C Linington
Journal:  J Neuroimmunol       Date:  1995-12       Impact factor: 3.478

9.  A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease.

Authors:  H J Schluesener; R A Sobel; C Linington; H L Weiner
Journal:  J Immunol       Date:  1987-12-15       Impact factor: 5.422

10.  Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls.

Authors:  B G Xiao; C Linington; H Link
Journal:  J Neuroimmunol       Date:  1991-02       Impact factor: 3.478

View more
  27 in total

1.  Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more.

Authors:  Marie Cathrin Mayer; Edgar Meinl
Journal:  Ther Adv Neurol Disord       Date:  2012-05       Impact factor: 6.570

2.  Interaction of loci within the HLA region influences multiple sclerosis course in the Sardinian population.

Authors:  M G Marrosu; E Cocco; G Costa; M R Murru; C Mancosu; R Murru; M Lai; C Sardu; P Contu
Journal:  J Neurol       Date:  2005-08-17       Impact factor: 4.849

3.  Myelin Oligodendrocyte Glycoprotein-IgG Contributes to Oligodendrocytopathy in the Presence of Complement, Distinct from Astrocytopathy Induced by AQP4-IgG.

Authors:  Ling Fang; Xinmei Kang; Zhen Wang; Shisi Wang; Jingqi Wang; Yifan Zhou; Chen Chen; Xiaobo Sun; Yaping Yan; Allan G Kermode; Lisheng Peng; Wei Qiu
Journal:  Neurosci Bull       Date:  2019-04-30       Impact factor: 5.203

4.  Role of pathogenic T cells and autoantibodies in relapse and progression of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in LEW.1AV1 rats.

Authors:  Yoh Matsumoto; Il-Kwon Park; Keiko Hiraki; Shin Ohtani; Kuniko Kohyama
Journal:  Immunology       Date:  2008-10-29       Impact factor: 7.397

5.  Antigen specificity of clonally expanded and receptor edited cerebrospinal fluid B cells from patients with relapsing remitting MS.

Authors:  Doris Lambracht-Washington; Kevin C O'Connor; Elizabeth M Cameron; Andrea Jowdry; E Sally Ward; Elliot Frohman; Michael K Racke; Nancy L Monson
Journal:  J Neuroimmunol       Date:  2007-04-23       Impact factor: 3.478

6.  The crystal structure of myelin oligodendrocyte glycoprotein, a key autoantigen in multiple sclerosis.

Authors:  Craig S Clements; Hugh H Reid; Travis Beddoe; Fleur E Tynan; Matthew A Perugini; Terrance G Johns; Claude C A Bernard; Jamie Rossjohn
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-05       Impact factor: 11.205

7.  Role of B:T cell ratio in suppression of clinical signs: a model for silent MS.

Authors:  Lisa K Peterson; Ikuo Tsunoda; Jane E Libbey; Robert S Fujinami
Journal:  Exp Mol Pathol       Date:  2008-04-08       Impact factor: 3.362

Review 8.  Immune tolerance to myelin proteins.

Authors:  Audrey Seamons; Antoine Perchellet; Joan Goverman
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

9.  Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis.

Authors:  Patrice H Lalive; Til Menge; Cecile Delarasse; Bruno Della Gaspera; Danielle Pham-Dinh; Pablo Villoslada; H-C von Büdingen; Claude P Genain
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-03       Impact factor: 11.205

10.  Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells.

Authors:  Bernadette Pöllinger; Gurumoorthy Krishnamoorthy; Kerstin Berer; Hans Lassmann; Michael R Bösl; Robert Dunn; Helena S Domingues; Andreas Holz; Florian C Kurschus; Hartmut Wekerle
Journal:  J Exp Med       Date:  2009-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.